TY  - JOUR
AU  - García-Álvarez, Ana
AU  - Blanco, Isabel
AU  - García-Lunar, Inés
AU  - Jordà, Paloma
AU  - Rodriguez-Arias, Juan J
AU  - Fernández-Friera, Leticia
AU  - Zegri, Isabel
AU  - Nuche, Jorge
AU  - Gomez-Bueno, Manuel
AU  - Prat, Susanna
AU  - Pujadas, Sandra
AU  - Sole-Gonzalez, Eduard
AU  - Garcia-Cossio, Maria D
AU  - Rivas, Mercedes
AU  - Torrecilla, Estefanía
AU  - Pereda, Daniel
AU  - Sanchez, Javier
AU  - García-Pavía, Pablo
AU  - Segovia-Cubero, Javier
AU  - Delgado, Juan F
AU  - Mirabet, Sonia
AU  - Fuster, Valentín
AU  - Barberá, Joan A
AU  - Ibáñez, Borja
PY  - 2023
DO  - 10.1002/ejhf.2745
UR  - http://hdl.handle.net/20.500.12105/16452
AB  - AIMSPulmonary hypertension (PH) associated with left heart disease is an increasingly prevalent problem, orphan of targeted therapies, and related to a poor prognosis, particularly when pre- and post-capillary PH combine. The current study aimed to...
LA  - eng
PB  - Wiley
KW  - Hypertension, Pulmonary
KW  - Heart Failure
KW  - Humans
KW  - Quality of Life
KW  - Stroke Volume
KW  - Adrenergic Agonists
KW  - Double-Blind Method
KW  - Treatment Outcome
TI  - β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial.
TY  - journal article
ER  -